Equillium, Inc. (EQ)
2.26
+0.06
(+2.49%)
USD |
NASDAQ |
Sep 02, 14:16
Equillium Research and Development Expense (Annual) : 12.84M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 12.84M |
| December 31, 2024 | 37.43M |
| December 31, 2023 | 37.04M |
| December 31, 2022 | 37.55M |
| December 31, 2021 | 26.38M |
| Date | Value |
|---|---|
| December 31, 2020 | 19.38M |
| December 31, 2019 | 17.64M |
| December 31, 2018 | 4.943M |
| December 31, 2017 | 1.334M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Fortress Biotech, Inc. | 11.90M |
| Cue Biopharma, Inc. | 37.43M |
| Legend Biotech Corp. | 415.80M |
| Dianthus Therapeutics, Inc. | 145.64M |